New Product Watch | GenomeWeb

New Product Watch

Premium

Agilent Technologies this week launched its SureSelect Kinome Target Enrichment Kit. The kit enables researchers to focus their next-generation sequencing studies on expressed kinases, the firm said.

Agilent's new assay was developed with Rene Bernards of the Netherlands Cancer Institute and targets genes for greater than 500 known kinases plus a number of cancer genes and untranslated regions. Customers can use Agilent's eArray xD tool to design custom kits.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.